Table 3.
Clinical medicine with anti-aging activities
| CAS | Chemicals | Structure | Clinical application | Anti-aging activity and proposed anti-aging mechanism |
|---|---|---|---|---|
| With anti-aging activities in a variety of aging models | ||||
| 58-08-2 | Caffeine |
|
Psychoactive drug | In rats: antioxidant, alleviating neuroinflammation and neurodegeneration [75] In zebrafish: 29.4% increase in mean lifespan and regulating proteostasis [74] In C. elegans: 29.4% increase in mean lifespan and regulating IIS pathway and proteostasis [73] |
| 657-24-9 | Metformin |
|
Treatment of type 2 diabetes and polycystic ovary syndrome | In rats: altering erythrocyte redox status [70] In D. melanogaster: has not effect on fecundity or lifespan and activating AMPK, reducing lipid stores [72] In C. elegans: 40.0% increase in mean lifespan and regulating AMPK, LKB1, and SKN-1 [71] |
| 53123-88-9 | Rapamycin |
|
Used to coat coronary stents, prevent organ transplant rejection and to treat a rare lung disease called lymphangioleiomyomatosis | In mice: 14.0% increase in mean lifespan for females and 9% for males and reducing mTOR activity [76–82] In D. melanogaster: 13.0% increase in mean lifespan and regulating TORC1 branch of the TOR pathway, through alterations to both autophagy and translation [83] In C. elegans: 19.0% increase in mean lifespan and regulating TOR, SKN-1 and DAF-16 [84] |
| With anti-aging activities in two aging models | ||||
| 50-78-2 | Aspirin |
|
Used to treat pain, fever, and inflammation | In genetically heterogeneous male mice: 8.0% increase in mean lifespan and needs further research [135] In C. elegans: 30.0% increase in mean lifespan and antioxidant, regulating AMPK and insulin-like signaling pathway [183, 308] |
| 2086-83-1 | Berberine |
|
Used to treat bacillary dysentery and gastroenteritis | In aged mice: suppressing neuroinflammation, reducing vascular stiffness in aged mice through suppression of TRPV4 [309, 310] In D. melanogaster: 46.0% increase in mean lifespan and inhibiting kynurenine (KYN) formation from tryptophan (TRP) [311] |
| 102518-79-6 | Huperzine A |
|
Treatment for neurological conditions such as Alzheimer’s disease | In d-galactose-induced mice: inhibiting DAMPs-mediated NF-κB nuclear localization and activation [312] In C. elegans: 14.0% increase in mean lifespan and needs further research [285] |
| 10118-90-8 | Minocycline |
|
Antibiotic | In D. melanogaster: 63.0% increase in mean lifespan and antioxidant [313] In C. elegans: 29.0% increase in mean lifespan and antioxidant [176] |
| 114-86-3 | Phenformin |
|
Antidiabetic | In mice: 21.0% increase in mean lifespan and decreasing the body weight, slowing down the age-related decline of the reproductive function in female rats [314] In C. elegans: 29.0% increase in mean lifespan and needs further research [315] |
| 59-02-9 | Vitamin E |
|
Vitamins | In rats: reducing the oxidative stress increased in old age [316, 317] In C. elegans: 23.0% increase in mean lifespan and antioxidant [318] |
| With anti-aging activities in rats or mice | ||||
| 692-13-7 | Buformin |
|
Antidiabetic | In rats: 7.0% increase in mean lifespan in female and decreasing the body weight, slowing down the age-related decline of the reproductive function in female rats [314] |
| 73-31-4 | Melatonin |
|
Regulating sleep and wakefulness | In male Wistar: restoring rSocs1 rhythms and levels in various tissues [319] |
| 155974-00-8 | Ivabradine |
|
Used for the symptomatic management of stable heart related chest pain and heart failure | In C57BL/6 J mice: 6.0% increase in mean lifespan and reducing heart rate [320] |
| 56180-94-0 | Acarbose |
|
Antidiabetic | In SAMP8 mice and male mice: 22.0% increase in mean lifespan and changing in the insulin system and the levels of BDNF, IGF-1R, and the pre-synaptic proteins Syt1 and Stx1 [321, 322] |
| 51384-51-1 | Metoprolol |
|
Used to treat high blood pressure, chest pain due to poor blood flow to the heart, and a number of conditions involving an abnormally fast heart rate | In mice: 10.0% increase in mean lifespan and needs further research [323] |
| 99200-09-6 | Nebivolol |
|
Treatment of hypertension | In mice: 6.4% increase in mean lifespan and needs further research [323] |
| With anti-aging activities in Drosophila melanogaster | ||||
| 13123-37-0 | Riboflavin |
|
Vitamin | 14.1% increase in mean lifespan and increasing SOD1 and CAT, inhibiting LF [324] |
| 84057-84-1 | Lamotrigine |
|
Anticonvulsant | 17.0% increase in mean lifespan and reducing locomotor activity and metabolic rate [325] |
| 1716-12-7 | 4-Phenyl-butyrate |
|
Used to treat urea cycle disorder | 40.0% increase in mean lifespan and increasing histone acetylation [326] |
| 52757-95-6 | Sevelamer |
|
Used to treat hyperphosphatemia in patients with chronic kidney disease | 16.0% increase in mean lifespan and regulating cellular and organismic phosphate levels [327] |
| 79902-63-9 | Simvastatin |
|
Hypolipidemic | 25.0% increase in mean lifespan and decreasing specific protein prenylation [328] |
| 871700-17-3 | Trametinib |
|
Anti-cancer | 12.0% increase in mean lifespan and inhibiting Ras-Erk-ETS signaling [329] |
| 58880-19-6 | Trichostatin A |
|
Antifungal antibiotic | 27.0% increase in mean lifespan and changing the level of histone acetylation, influencing the expression of hsp22 gene [330] |
| 57-27-2 | Morphine |
|
Treatment of acute pain and chronic pain | 22.0% increase in mean lifespan and needs further research [331] |
| With anti-aging activities in Caenorhabditis elegans | ||||
| 14028-44-5 | Amoxapine |
|
Antidepressant | 33.0% increase in mean lifespan and antioxidant [176] |
| 298-57-7 | Cinnarizine |
|
Treatment of vertigo, motion sickness, and vomiting | 15.0% increase in mean lifespan and antioxidant [176] |
| 59865-13-3 | Cyclosporin A |
|
Immunosuppressants | 18.0% increase in mean lifespan and antioxidant [176] |
| 427-51-0 | Cyproterone acetate |
|
Antiandrogen and progestogen | 23.0% increase in mean lifespan and antioxidant [176] |
| 17230-88-5 | Danazol |
|
Treatment of endometriosis | 13.0% increase in mean lifespan and antioxidant [176] |
| 127-33-3 | Demeclocycline hydrochloride |
|
Antibiotic | 16.0% increase in mean lifespan and antioxidant [176] |
| 564-25-0 | Doxycycline |
|
Antibiotic | 18.0% increase in mean lifespan and antioxidant [176] |
| 10592-13-9 | Doxycycline hydrochloride |
|
Antibiotic | 18.0% increase in mean lifespan and antioxidant [176] |
| 119431-25-3 | Eliprodil |
|
NMDA antagonist, treatment of acute ischemic stroke | 16.0% increase in mean lifespan and antioxidant [176] |
| 23256-50-0 | Guanabenz acetate |
|
Antihypertensive | 12.0% increase in mean lifespan and antioxidant [176] |
| 29110-48-3 | Guanfacine hydrochloride |
|
Treatment of hyperactivity | 15.0% increase in mean lifespan and antioxidant [176] |
| 27833-64-3 | Loxapine succinate |
|
Antipsychotic | 43.0% increase in mean lifespan and antioxidant [176] |
| 57149-08-3 | Naftopidil di-hydrochloride |
|
Antihypertensive | 14.0% increase in mean lifespan and antioxidant [176] |
| 54527-84-3 | Nicardipine hydrochloride |
|
Used to treat high blood pressure and angina | 23.0% increase in mean lifespan and antioxidant [176] |
| 39562-70-4 | Nitrendipine |
|
Used in the treatment of primary (essential) hypertension to decrease blood pressure and can reduce the cardiotoxicity of cocaine | 25.0% increase in mean lifespan and antioxidant [176] |
| 894-71-3 | Nortriptyline hydrochloride |
|
Tricyclic antidepressant | 21.0% increase in mean lifespan and antioxidant [176] |
| 60607-34-3 | Oxatomide |
|
Anti-allergic | 25.0% increase in mean lifespan and antioxidant [176] |
| 130-61-0 | Thioridazine hydrochloride |
|
Antipsychotic | 31.0% increase in mean lifespan and antioxidant [176] |
| 2068-78-2 | Vincristine sulfate |
|
Anti-cancer | 12.0% increase in mean lifespan and antioxidant [176] |
| 97-59-6 | Allantoin |
|
Used to treat gastric ulcer, duodenal bulb ulcer, chronic gastritis | 21.9% increase in mean lifespan and caloric restriction mimetics [332] |
| 169590-42-5 | Celecoxib |
|
COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain | 19.0% increase in mean lifespan and inhibiting insulin-like signaling [333] |
| 99-66-1 | Valproic acid |
|
Used to treat epilepsy and bipolar disorder and to prevent migraine headaches | 35.0% increase in mean lifespan and regulating IIS pathway [334] |
| 103-90-2 | Acetaminophen |
|
Used to treat pain and fever | 49.0% increase in mean lifespan and regulating CBP-1 [224] |
| 69-52-3 | Ampicillin |
|
Antibiotic | 34.0% increase in mean lifespan and antimicrobial [284] |
| 41859-67-0 | Bezafibrate |
|
Treatment of hypertriglyceridemia | 13.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] |
| 637-07-0 | Clofibrate |
|
Lipid-lowering agent used for controlling the high cholesterol and triacylglyceride level in the blood | 16.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] |
| 49562-28-9 | Fenofibrate |
|
Used to reduce cholesterol levels in people at risk of cardiovascular disease | 19.0% increase in mean lifespan and regulating NHR-49/PPARalpha-dependent manner [335] |
| 127-48-0 | Trimethadione |
|
Anticonvulsant | 47.0% increase in mean lifespan and regulating neuromuscular activity [336] |
| 42971-09-5 | Vinpocetine |
|
Treatment of cerebrovascular disorders and age-related memory impairment | 15.0% increase in mean lifespan and regulating PDE1 [176] |
| 59-30-3 | Folic acid |
|
Used to treat anemia caused by folic acid deficiency | 27.0% increase in mean lifespan and antioxidant, regulating SIR-2.1, SKN-1, and DAF-16 [337] |
| 77-67-8 | Ethosuximide |
|
Used to treat absence seizures | 17.0% increase in mean lifespan and disrupting sensory function, regulating DAF-16 [336, 338, 339] |
| 50264-69-2 | Lonidamine |
|
Anti-cancer | 8.0% increase in mean lifespan and promoting longevity in a pmk-1sensitive manner by increasing formation of ROS [340] |
| 50-55-5 | Reserpine |
|
Antipsychotic, and antihypertensive | 31.0% increase in mean lifespan and antioxidant, modulating acetylcholine release [341, 342] |
| 13292-46-1 | Rifampicin |
|
Antibiotic | 56.0% increase in mean lifespan and reducing advanced glycation end products and activating DAF-16 [343] |
| 6998-60-3 | Rifamycin SV |
|
Antibiotic | 21.0% increase in mean lifespan and reducing advanced glycation end products and activating DAF-16 [343] |
| 723-46-6 | Sulfa-methoxazole |
|
Antibiotic | 34.0% increase in mean lifespan and increasing lipid peroxidation oxidative stress [344] |
| 56-75-7 | Chloram-phenicol |
|
Antibiotic | 16.0% increase in mean lifespan and needs further research [345] |
| With anti-aging activities in other aging models | ||||
| 53-06-5 | Cortisone |
|
Used to reduce inflammation and attendant pain and swelling at the site of the injury | In Asplanchna brightwelli: 21.0% increase in mean lifespan and stabilizing lysosomal membranes, or altering resource allocation by the rotifers [346] |
| 35891-70-4 | Myriocin |
|
Antibiotic ISP-1 and thermozymocidin | In S. cerevisiae: activating the Snf1/AMPK pathway, down-regulating the protein kinase A (PKA) and target of rapamycin complex 1 (TORC1) pathways [347] |